For Q3 FY2025, net sales were 195.4 billion yen (12% YoY increase), operating income was 45.0 billion yen (10% YoY increase), and net income was 35.0 billion yen (11% YoY increase), with no revisions to the full-year earnings forecast.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4021","jir_company_name":"Nissan Chemical Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-02-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4021-20260209-02.pdf","jir_short_summary":"For Q3 FY2025, net sales were 195.4 billion yen (12% YoY increase), operating income was 45.0 billion yen (10% YoY increase), and net income was 35.0 billion yen (11% YoY increase), with no revisions to the full-year earnings forecast.","jir_summary":"### Overview of Financial Results\nIn the consolidated Q3 FY2025 results, net sales amounted to 195.4 billion yen (12% YoY increase), operating income reached 45.0 billion yen (10% YoY increase), and net income was 35.0 billion yen (11% YoY increase). The third quarter alone recorded net sales of 65.3 billion yen (15% YoY increase), operating income of 15.4 billion yen (21% YoY increase), and net income of 12.2 billion yen (9% YoY increase), indicating growth in both revenue and profits. By segment, Functional Materials and Agricultural Chemicals achieved growth in both sales and profits, Chemicals declined in sales, and Healthcare remained flat.\n\n### Shareholder Returns and Outlook\nThe dividend forecast is set at 180 yen for the full year, a 6 yen increase from the previous year, with no changes from the forecast announced in November 2025. The company is conducting share buybacks totaling 10.5 billion yen, of which 1.5 billion yen was completed in April 2025 and 9.0 billion yen is planned to be completed by February 2026. The total return ratio is expected to be 78.8%. There are no revisions to the full-year earnings forecast since the November 2025 announcement, indicating a policy of stable growth and continued shareholder returns.","jir_financial_highlights":"Net Sales: 195.4 billion yen (12% YoY increase)\nOperating Income: 45.0 billion yen (10% YoY increase)\nNet Income: 35.0 billion yen (11% YoY increase)\nDividend Forecast: Full-year 180 yen (6 yen increase YoY)\nShare Buyback: 10.5 billion yen (Unknown)\nTotal Return Ratio Forecast: 78.8% (Unknown)","jir_category":"","jir_hashtags":"#NissanChemical, #FinancialResultsBriefing, #JapaneseStocks","jir_key_figures":"Net Sales: 195.4 billion yen (12% YoY increase)\nOperating Income: 45.0 billion yen (10% YoY increase)\nNet Income: 35.0 billion yen (11% YoY increase)","jir_meta_title":"Nissan Chemical FY2026 March Q3 Financials: Net Sales 195.4 Billion Yen, 12% Increase","jir_meta_description":"Nissan Chemical's FY2026 March Q3 financial results show net sales of 195.4 billion yen (12% YoY increase), operating income of 45.0 billion yen (10% YoY increase), and net income of 35.0 billion yen (11% YoY increase). Dividend is planned to increase to 180 yen.","jir_og_title":"Nissan Chemical FY2026 Q3 Financial Results Announcement: 12% Net Sales Growth","jir_og_description":"Nissan Chemical's FY2026 Q3 results show revenue and profit growth. Dividend increase and share buyback continue, demonstrating stable growth.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (100 million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2016\\\",\\\"FY2017\\\",\\\"FY2018\\\",\\\"FY2019\\\",\\\"FY2020\\\",\\\"FY2021\\\",\\\"FY2022\\\",\\\"FY2023\\\",\\\"FY2024\\\",\\\"FY2025 (Forecast)\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[528,588,630,655,716,817,826,846,1001,1097],\\\"borderColor\\\":\\\"#007bff\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (100 million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2016\\\",\\\"FY2017\\\",\\\"FY2018\\\",\\\"FY2019\\\",\\\"FY2020\\\",\\\"FY2021\\\",\\\"FY2022\\\",\\\"FY2023\\\",\\\"FY2024\\\",\\\"FY2025 (Forecast)\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[125,142,150,170,224,276,254,225,293,321],\\\"borderColor\\\":\\\"#28a745\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"FY2025 Segment Revenue Composition\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Functional Materials\\\",\\\"Agricultural Chemicals\\\",\\\"Chemicals\\\",\\\"Healthcare\\\",\\\"Others\\\"],\\\"datasets\\\":[{\\\"data\\\":[1097,959,396,53,217],\\\"backgroundColor\\\":[\\\"#007bff\\\",\\\"#28a745\\\",\\\"#ffc107\\\",\\\"#dc3545\\\",\\\"#6c757d\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"right\\\"}}}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Margin Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2016\\\",\\\"FY2017\\\",\\\"FY2018\\\",\\\"FY2019\\\",\\\"FY2020\\\",\\\"FY2021\\\",\\\"FY2022\\\",\\\"FY2023\\\",\\\"FY2024\\\",\\\"FY2025 (Forecast)\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin (%)\\\",\\\"data\\\":[23.7,24.1,23.8,26.0,31.3,33.8,30.8,26.6,29.3,29.3],\\\"borderColor\\\":\\\"#17a2b8\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true,\\\"max\\\":40}}}}\"}]","ir_related_company":7700,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-26031","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n